Detalles de la búsqueda
1.
Evaluation of Empirical Dosing Regimens for Meropenem in Intensive Care Unit Patients Using Population Pharmacokinetic Modeling and Target Attainment Analysis.
Antimicrob Agents Chemother;
67(1): e0131222, 2023 01 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-36622154
2.
Population pharmacokinetics and target attainment analyses to identify a rational empirical dosing strategy for cefepime in critically ill patients.
J Antimicrob Chemother;
78(6): 1460-1470, 2023 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37071586
3.
Systematic Down-Selection of Repurposed Drug Candidates for COVID-19.
Int J Mol Sci;
23(19)2022 Oct 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36233149
4.
Population pharmacokinetics of free flucloxacillin in patients treated with oral flucloxacillin plus probenecid.
Br J Clin Pharmacol;
87(12): 4681-4690, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33963595
5.
New Horizons in the impact of frailty on pharmacokinetics: latest developments.
Age Ageing;
50(4): 1054-1063, 2021 06 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-33751018
6.
Meropenem-Tobramycin Combination Regimens Combat Carbapenem-Resistant Pseudomonas aeruginosa in the Hollow-Fiber Infection Model Simulating Augmented Renal Clearance in Critically Ill Patients.
Antimicrob Agents Chemother;
64(1)2019 12 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-31636062
7.
Optimizing vancomycin dosage regimens in relation to high-flux haemodialysis.
J Antimicrob Chemother;
74(1): 130-134, 2019 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30215721
8.
An analysis of allele, genotype and phenotype frequencies, actionable pharmacogenomic (PGx) variants and phenoconversion in 5408 Australian patients genotyped for CYP2D6, CYP2C19, CYP2C9 and VKORC1 genes.
J Neural Transm (Vienna);
126(1): 5-18, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-30191366
9.
Optimization and Evaluation of Piperacillin-Tobramycin Combination Dosage Regimens against Pseudomonas aeruginosa for Patients with Altered Pharmacokinetics via the Hollow-Fiber Infection Model and Mechanism-Based Modeling.
Antimicrob Agents Chemother;
62(5)2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29463528
10.
Consistent terminology for medication-related problems in pharmacogenomic cases.
J Psychiatry Neurosci;
48(3): E151-E152, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37172962
11.
Substantial Impact of Altered Pharmacokinetics in Critically Ill Patients on the Antibacterial Effects of Meropenem Evaluated via the Dynamic Hollow-Fiber Infection Model.
Antimicrob Agents Chemother;
61(5)2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28264846
12.
Patterns of use and appropriateness of antibiotics prescribed to patients receiving haemodialysis: an observational study.
BMC Nephrol;
18(1): 156, 2017 May 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-28499421
13.
Identification of major factors in Australian primary care pharmacists' practice environment that have a bearing on the implementation of professional models of practice.
Aust Health Rev;
41(4): 378-383, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-27632343
14.
Effect of different renal function on antibacterial effects of piperacillin against Pseudomonas aeruginosa evaluated via the hollow-fibre infection model and mechanism-based modelling.
J Antimicrob Chemother;
71(9): 2509-20, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27231278
15.
Primary antifungal prophylaxis in adult patients with acute lymphoblastic leukaemia: a multicentre audit.
J Antimicrob Chemother;
71(2): 497-505, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26518050
16.
Science fiction has become reality: Best practice for future viral pandemics.
Br J Clin Pharmacol;
87(9): 3385-3387, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34296460
17.
A call for the appropriate application of clinical pharmacological principles in the search for safe and efficacious COVID-19 (SARS-COV-2) treatments.
Br J Clin Pharmacol;
87(3): 707-711, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32515023
18.
Are interstitial fluid concentrations of meropenem equivalent to plasma concentrations in critically ill patients receiving continuous renal replacement therapy?
J Antimicrob Chemother;
70(2): 528-33, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25336163
19.
Plasma and target-site subcutaneous tissue population pharmacokinetics and dosing simulations of cefazolin in post-trauma critically ill patients.
J Antimicrob Chemother;
70(5): 1495-502, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25608584
20.
Are standard doses of piperacillin sufficient for critically ill patients with augmented creatinine clearance?
Crit Care;
19: 28, 2015 Jan 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-25632974